三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ZG005-001项目患者基线(n,%)
ZG005-001项目患者基线(n,%)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:257KB
图片尺寸:1138*855
同报告图片
/
4
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
所属报告:
泽璟制药-公司研究报告-创新进入收获期ZG006及ZG005均有望成为BIC-250714(37页).pdf
打包全文图表
相关数据
ZG005治疗宫颈癌患者的无进展生存期(IRC评估)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
ZG005和AK104在宫颈癌的数据对比(截至20250720)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
ZG005:一线晚期神经内分泌癌中显示良好的有效性和安全性
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
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005:一线晚期宫颈癌中显示优异的有效性及安全性
fCDkuLTluormlrnmoYggfCBaRzAwNSDliYLph48gfCDljJbnlpfoja/niakgfCDotJ3kvJDljZXmipcgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgSeacnyB8IDIwIG1nL2tnIHwg5YyW55aXIHwg6LSd5LyQ5Y2V5oqXIHwKfCBJ5pyfIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMjAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAoK6LWE5paZ5p2l5rqQ77yaQVNDT++8jOWFrOWPuOWFrOWRiu+8jOS4nOWQtOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005-001项目不良反应(n,%)
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
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005I期安全性数据
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
收藏
其它
2024-06-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
截至 2024 年 12 月 5 日,ZG005-001 项目 I 期剂量递增阶段已完成;II 期剂量扩展阶段中,共 55 例二线及以上宫颈癌患者接受(ZG005)治疗,按 1:1 随机接受 10 mg/kg Q3W 或 20 mg/kg Q3W 治疗。①有效性方面,既往未接受过免疫检查点抑制剂治疗的二线及以上宫颈癌患者中,20 mg/kg 组(N=22)基于 IRC 评估的确认 ORR 为 40.9%,DCR为 68.2%。基于研究者评估,20 mg/kg 组 mPFS 已超过 11 个月。②安全性方面,两组整体耐受性和安全性均良好,83.6%的患者发生 TRAE,绝大多数为 1-2 级,仅 9.1%为≥3级,未发生因 TEAE 导致的死亡。
行业数据
原图定位
当前图表所属:
泽璟制药-公司研究报告-创新进入收获期ZG006及ZG005均有望成为BIC-250714(37页).pdf
自免疾病具备广阔的临床应用和市场潜力
PD-1/TIGIT药物主要进展(截至2025H1)
CD3/DLL3主要相关药物临床进展(截至2025H1)
小细胞肺癌免疫治疗专家共识(2025版)要点
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》